×
We strive to exploit the full potential of the body's immune system by combining powerful new therapeutic mechanisms and a diverse array of biological targets ...
BioNTech SE

BioNTech SE

Biotechnology company
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. Wikipedia
CEO: Uğur Şahin (2008–)
Founded: 2008
Headquarters: Germany

People also ask
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the ...
Biopharmaceutical New Technologies, or BioNTech, is a global, fully integrated next-generation immunotherapy company pioneering novel therapies for cancer, ...
Press Releases · 6 May 2024. BioNTech Announces First Quarter 2024 Financial Results and Corporate Update · 22 April 2024. BioNTech to Report First Quarter 2024 ...
Our aim is to provide therapeutic benefits for cancer patients along the entire treatment journey. https://investors.biontech.de/news-releases/news-release- ...
Pfizer-BioNTech COVID-19 Vaccine (2023-2024 Formula) Authorized For Individuals 6 Months through 11 Years of Age.
BioNTech SE | 237712 followers on LinkedIn. Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious ...